LSC will consider licensing and development for custom design co-engineering of Hydroxysomes® with any API / bioactive including hydrophilic and hydrophobic actives. LSC will be responsible for the development and manufacturing of the new innovative active raw material.
This includes:
Pharmaceutical Applications: